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Abstract
Background: Superior mesenteric artery syndrome is best described as compression of the third part of duodenum by the superior mesenteric artery, 
resulting in obstruction. This rare condition has been studied for decades yet remains obscure. This study aimed to analyze different clinical presentations, 
diagnostic modalities, treatment approaches and outcomes of this condition. Methods: Thirty-five superior mesenteric artery syndrome cases were 
collected retrospectively from a Facebook group called “Superior Mesenteric Artery Syndrome Awareness & Support”. A questionnaire was designed using 
Google Forms to obtain the demographics, presenting symptoms, risk factors and co-morbidities, investigations, means of treatment and the outcomes. 
Data was entered into Microsoft Office Excel for statistical analysis. Results: The median age at diagnosis was 22 years. The median body mass index 
was 20.8 kg/m2. The median time interval from symptom onset to initial diagnosis was 22 months. The major presenting symptoms were abdominal 
pain (82.9%), nausea (77.1%), and vomiting (65.7%). Abdominal computed tomography scan with contrast (82.9%) was commonly used for confirmation 
of diagnosis. Thirteen cases (37.1%) were congenital. Thirty patients (85.7%) had received treatment. The overall management success was only 13.3%. 
Surgical management (34.3%) was the most commonly used regimen. Conclusion: Diagnosis of superior mesenteric artery syndrome is established after a 
thorough assessment of the clinical presentations and confirmed with suitable imaging modalities. The choice of treatment should be dependent on the 
causes and severity as different patients respond differently to therapy. Recurrence is possible in all patients, and a long-term follow up is thus required.
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Introduction
Superior mesenteric artery syndrome (SMAS) is a rare medical 
condition caused by compressive obstruction of the transverse 
or ascending portion of duodenum by the superior mesenteric 
artery (SMA).1-6 The obstruction results from the loss of the 
intervening mesenteric fat pad between the aorta and SMA, 
leading to narrowing of the angle between these two vesse-
ls.7,8 Duodenal compression by the SMA was first described as 
results of autopsy by Carl Freiherr von Rokitansky in 1861.3,6,8-12 
It has since been given other names such as aortomesenteric 
artery compression, arteriomesenteric artery duodenal com-
pression, duodenal vascular compression, cast syndrome and 
Wilkie syndrome.1,7,9 Wilkie explicated the clinical pathology in 
1927, and since then more cases were reported.1,2,5,7,8,12,13
SMA arises from the abdominal aorta at the level of the first 
lumbar vertebra.2,4,9,14,15 It usually leaves the aorta at an angle 
of 25°–60°, leaving a considerable space for the left renal vein, 
third portion of duodenum, and uncinate process of the pan-
creas to pass through.15,16 The distance between the SMA and 
the aorta normally ranges from 10–28 mm.12,16 The presence 
of retroperitoneal fat plays an important role to keep the an-
gle and distance within this normal range. Any factors which 
contribute to the loss of this fat such as rapid weight loss, 
increased lordosis and external pressure will risk an individual 
for the development of SMAS.1,9,14,17
SMAS is usually associated with common gastrointestinal obs-
truction symptoms such as abdominal pain, post-prandial ab-
dominal pain, nausea, vomiting, weight loss or poor weight 
gain, slow digestion or indigestion, bloating, abdominal disten-
tion, feeling of fullness despite small amount of food intake, 
malaise and lethargy. The exact etiology of SMAS is not known, 
but certain predisposing conditions are clearly recognized, 
such as thin body build, rapid linear growth, severe injuries, 
dietary disorders especially anorexia nervosa, anatomic ano-
malies, central nervous system and spinal disease.3-5,7-9,11,14,18,19
The diagnosis of SMAS is frequently made by exclusion and 
relies on a high index of suspicion.8,14,19 The symptoms of this 
disorder may resemble many other gastrointestinal problems 
thus necessitating further confirmation by imaging.8,18 Upper 
gastrointestinal (UGI) series was once considered as the con-
firmatory test of choice.5,8 The radiologic criteria includes: (1) 
dilatation of the first and second parts of the duodenum, (2) 
an abrupt vertical or oblique compression of the third duo-
denal portion, (3) retrograde flow of the contrast proximal to 
the compression, (4) delay of transit of the contrast into je-
junum for at least 4–6 hours, and (5) a relief of the compres-
sion and symptoms in a knee-to-chest or left lateral decubitus 
position.9,20 Computed tomography (CT) scan or CT angiography 
(CTA) assess the aortomesenteric angle and distance as well 
as the extent of duodenal distension.3 In SMAS cases, the SMA 
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angle to the aorta is decreased to 6°–25°, whereas the distance 
is decreased to 2–8 mm.16
Therapy for SMAS can be either conservative or surgical de-
pending on the causes and severity. Conservative measures 
included weight gain, positioning, medications, enteral feeding, 
and parenteral feeding. Nasogastric decompression, correction 
of the fluid and electrolyte balance, and nutritional support 
are beneficial during an acute attack.7,9,21 Small, frequent high 
caloric diet with postprandial postural modifications such as 
knee-to-chest or right lateral decubitus and the use of proki-
netic drugs such as metoclopramide are recommended.7,9,18,20-22 
Enteral feeding by placement of nasojejunal tube distal to the 
obstruction is needed when oral feeding is not well-tolerated.15 
Total parenteral nutrition (TPN) can be an alternative.7 In both 
practices, the patients should be monitored for refeeding syn-
drome as it might occur easily in malnourished patients.14 
Surgical intervention is indicated when medical treatment fails. 
Other indications include long standing cases, profound dilata-
tion and stasis of the proximal small bowel, preference of the 
patient for surgical correction rather than prolonged conservati-
ve management, and the presence of associated diseases such 
as peptic ulcer and pancreatitis.10,11,23 The obstruction is prefe-
rably bypassed with an anastomosis such as gastrojejunostomy 
or duodenojejunostomy. Detachment of the duodenum away 
from the narrowed aortomesenteric angle through a procedure 
called Strong's procedure might be helpful. Some modifications 
to this technique may enhance the outcome, and this procedu-
re is known as duodenal de-rotation.
SMAS is a well-recognized clinical entity, yet the diagnosis is 
frequently delayed and the condition is often treated inappro-
priately due to the lack of awareness among physicians. It may 
resemble many other gastrointestinal problems, hence compli-
cating diagnosis, and may be followed by rapid progression to 
a life-threatening state such as malnutrition, dehydration, elec-
trolytes imbalance and even death.4,14,18 New studies in various 
aspects are needed to ensure early recognition of the condition 
together with improvement in the management and outcomes. 
The objective of this study is to analyze different clinical pre-
sentations, diagnostic modalities, treatment approaches and 
outcomes of SMAS. The outcomes of this study may be helpful 
in conducting future studies.
Methods
Thirty-five SMAS cases were collected retrospectively from a 
Facebook group called “Superior Mesenteric Artery (SMA) Sy-
ndrome Awareness & Support” over a period of two months. 
The group was established in November 2009 and has assem-
bled almost 2,000 members worldwide at present. It consists 
of SMAS patients, patients' friends, family and other members 
interested in this rare pathology. 
A questionnaire was designed using Google Forms and distri-
buted to the members on board. Strict rules were applied. Pa-
tients who were officially diagnosed were allowed to answer 
the questionnaire, regardless of treatment. The friends or fami-
ly members were allowed to fill the form only if the patient was 
severely ill or disabled. The data collected included demogra-
phics, presenting symptoms, risk factors and co-morbidities, 
investigations, means of treatment, and the outcomes.
Demographic information collected included sex, age at time 
of initial diagnosis, height and weight. The weight status of 
each patient was estimated by calculation of the body mass 
index (BMI). Assessment of the BMI was made according to 
the following classification: underweight (<18.5 kg/m2), normal 
(18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2), or obese (>30.0 
kg/m2). 
Both main and associated symptoms were recorded. Presen-
ting symptoms were analyzed according to the duration before 
diagnosis. Diagnosis established within six months from the 
onset of symptoms was considered an early diagnosis, whe-
reas those which took more than six months were considered 
to be late diagnosis. Possible predisposing factors for SMAS, 
presence of multiple co-morbidities, and surgical history for 
each case were explored. 
The management for each case was grouped into: conservative, 
surgical, or both. The evaluation of treatment outcomes was 
made by the patients and classified into four grades: excellent 
(no symptoms after using the treatment), good (mild tempo-
rary symptoms without any need for therapy), satisfactory 
(moderate occasional symptoms that can be controlled by a 
particular body position or medications), and poor (moderate 
or severe symptoms essentially the same as those experienced 
preoperatively). All information was entered into Microsoft Offi-
ce Excel 2007 spreadsheet for statistical analysis. 
Results
A total of 35 SMAS patients answered the questionnaire; 31 (88.6%) 
of these were females. The median age at diagnosis was 22 years, 
with a range of 12–59 years. The median BMI was 20.8 kg/m2, with 
a range of 14.2–26.4 kg/m2. Six patients (17.1%) were underweight, 
26 patients (74.3%) had a normal BMI, and three patients (8.6%) 
were overweight.
The median time interval from symptom onset to initial diagnosis 
was 22 months, with a range of 3–216 months. Only five patients 
(14.3%) were diagnosed early (Table 1). Most patients (94.3%) 
presented with more than one symptom. The major presenting 
symptoms were abdominal pain (82.9%), nausea (77.1%), and vo-
miting (65.7%). Other symptoms included weight loss (48.6%), fa-
tigue (34.3%), bloating (25.7%), feeling of fullness (17.1%), altered 
bowel habit (17.1%) and early satiety (11.4%), as shown in Table 1.
Twenty-nine patients (82.9%) underwent abdominal CT scan with 
contrast, 23 patients (65.7%) underwent barium UGI series, 17 
patients (48.6%) underwent endoscopy, 13 patients (37.1%) un-
derwent ultrasonography, and 12 patients (34.3%) underwent gas-
tric emptying study.
Thirteen patients (37.1%) had congenital SMAS, 11 (31.4%) had 
pre-morbid conditions, while the remaining 11 patients (31.4%) 
were free of co-morbidities. The most common co-morbid con-
dition was sudden weight loss, followed by spinal problems, ce-
rebral palsy, motor vehicle accident, history of anorexia, midgut 
mal-rotation, and iatrogenic (Table 1). About 60% of the cases were 
identified to have a previous surgical history prior to the diagnosis 
of SMAS.
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Conservative management was attempted in 18 patients (51.4%). 
Nine of them tried weight gain by consuming high caloric diets, 
three were given medications (antacids and anti-emetics), two 
practiced the knee-to-chest position after meals, 11 used a fee-
ding tube, and six had total TPN. Seven patients (38.9%) did not 
respond well to the regimens and were further treated surgically. 
A total of 19 patients (54.3%) underwent surgery. Duodenojeju-
nostomy was performed on 15 patients (79.0%), and two patients 
(10.5%) were treated with gastrojejunostomy. Other procedures in-
cluded Strong's procedure with duodenal de-rotation, SMA release, 
and untwisting of the malrotated duodenum (Table 2).
Discussion
In our study, we describe 35 SMAS patients who answered our 
questionnaire over a period of two months. Our data showed 
that females were affected more frequently than males, and 
the majority of patients were between 20–29 years of age. This 
finding is congruent with earlier studies, which reported the 
involvement of more than 64% female patients.5,7,13,19,21 Biank 
(2006) suggested that low BMI is not a prerequisite for the 
development of SMAS, which is in accordance with our study 
finding that 74.3% had normal BMI. However, the relationship 
between normal BMI and the occurrence of SMAS remains un-
clear.5
Several etiological factors contributing to SMAS have been re-
ported worldwide. Congenital anomalies, including a possible 
genetic predisposition such as high attachment of ligament of 
Treitz and hypertrophy of the ligament, midgut mal-rotation as 
found in one of our cases, and visceral ptosis may share their 
roles in compression of the duodenum.2,9,10,13,15 Visceral ptosis 
allows dragging of small intestines into the true pelvis without 
resting on the pelvic floor, causing excessive traction of the 
SMA hence duodenal compression.15
Another cause is depletion of mesenteric fat which occurs fo-
llowing severe and rapid weight loss, from debilitating injuries, 
during catabolic states in excessive burn, and intravenous drug 
addictions (cocaine and heroin) with daily minimal food in-
take.10,15,18 Among the patients who answered our survey, 14.3% 
had SMAS with sudden weight loss resulting from head injury, 
following brain surgery, hyperthyroidism, and psychological 
stress following Helicobacter pylori infection.
Compression from external devices (such as tight belts, wea-
ring body spica cast for long time periods in vertebrae treat-
ment) and spinal disease (such as increased lordosis) may 
cause traction of the SMA.1,2,9,10,15 One of our cases experienced 
external compression from outside the body resulting from a 
car accident, while two other patients had spinal lordosis fo-
llowing fall from an elevated height and scoliosis, respectively.
Disorders of the central nervous system may play a role in 
the occurrence of SMAS as we reviewed one case with cere-
bral palsy. Disabilities such as spastic quadriparesis, prolon-
ged supine positioning, immobilization in spinal orthosis, and 
lumbar lordosis occurring in patient with cerebral palsy may 
induce duodenal compression.4,7 Prior studies state that SMAS 
could occur with psychic disorders such as anorexia nervosa9,19 
and dietary disorders such as malabsorption.9 We recorded one 
case of anorexia nervosa with SMAS.
Patient condition n (%)
Symptom*
Abdominal pain 29 (82.9)
Nausea 27 (77.1)
Vomiting 23 (65.7)
Weight loss 17 (48.6)
Fatigue 12 (34.3)
Bloating 9 (25.7)
Feeling of fullness 6 (17.1)
Altered bowel habits 6 (17.1)
Early satiety 4 (11.4)
Time Interval
< 0.5 year 5 (14.3)
0.5–1 year 4 (11.4)
1–5 years 19 (54.3)
5–10 years 2 (5.7)




Sudden weight loss 5 (14.3)
Spinal problems 2 (5.7)
Cerebral palsy 1 (2.9)
Motor vehicle accident 1 (2.9)
History of anorexia 1 (2.9)
Iatrogenic 1 (2.9)
Table 1. Presenting Symptoms, Interval between Symptom Appearance 
and Diagnosis, and Pre-morbid Conditions of Survey Respondents
* Some patients presented with more than one symptom.
Management (n)
Outcome, n (%)
Excellent Good Satisfactory Poor Unclassified
Not treated (5) NA NA NA NA NA
Conservative (11) 2 (18.2) 4 (36.4) 2 (18.2) 3 (27.3) 0 (0.0)
Surgical (12) 1 (8.3) 2 (16.7) 3 (25.0) 5 (41.7) 1 (8.3)
Both (7) 1 (14.3) 0 (0.0) 3 (42.9) 3 (42.9) 0 (0.0)
Table 2. Subjective Patient Perspective on Management and Outcomes
NA=not applicable.
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success rate.19
Gastrojejunostomy is considered when both the stomach and 
duodenum are severely dilated or in the presence of a duode-
nal ulcer.1,9,13,14 Difficulty in mobilizing the duodenum during a 
duodenojejunostomy or other procedures although indicated, 
may also requires this measure.14 It provides adequate gas-
tric decompression but fails to completely release duodenal 
obstruction resulting in recurrent symptoms requiring another 
procedure.5,19 Some well-known complications include dum-
ping syndrome, blind loop syndrome, gastric bile reflux and 
marginal ulceration.1,15,20 Two (10.5%) of our cases underwent 
gastrojejunostomy. One of the patients was doing well after 
the surgery with little weight gain. However, the symptoms 
reappeared after four months and was reported to be milder 
than before.
Duodenojejunostomy was performed on 15 patients (79.0%). 
This method has been favored and the vast majority of results 
have been excellent, with Wilkie alone reported to have suc-
cessfully performed it on 64 patients with SMAS.13,15 Advances 
in laparoscopic surgery have led to reports of laparoscopic duo-
denojejunostomy showing excellent outcomes which was pio-
neered by Gersin and Heniford in 1998.5 Surprisingly, only two 
(13.3%) of the respondents were successfully treated by this 
approach in spite of the high success rate reported by most 
authors. Symptoms persist in 80% of them (12 of 15 patients). 
The lack of detailed assessment of patients' condition and the 
presence of SMAS complications pre-operatively may contribu-
te to the failure of such procedure. One had just underwent 
laparoscopic duodenojejunostomy five months prior to the sur-
gery, thus making the outcome assessment impossible.
As both approaches produce interruption to the bowel integrity, 
Strong's operation has been advocated.4,9,22 The procedure was 
pioneered by Strong in 1958 when he stressed on the signi-
ficance of mechanical obstruction on the duodenum caused 
by high insertion of the ligament of Treitz. It involves division 
of the ligament of Treitz with mobilization of the transverse 
and ascending duodenum caudally, away from the apex of the 
aortomesenteric angle.8 However, this technique was reported 
to have an unacceptably high failure rate, probably due to 
post-operative adhesions and the interference of downward 
duodenal displacement by the short branches of inferior pan-
creaticoduodenal artery to the duodenum.11 Hence, modifica-
tion of this technique has been proposed and extensively prac-
ticed since 1974. Passage of the jejunum and ileum underneath 
the superior mesenteric vessels into the right side of the ab-
domen following Strong's procedure can give a better outcome. 
The ascending colon is then separated from its retroperitoneal 
attachments and placed in the left side of the abdomen. The 
end result is a configuration similar to that seen in congenital 
mal-rotation of the intestine.8 One of the respondents in our 
study first underwent Strong's procedure laparoscopically, but 
it was deemed unsuccessful. An open duodenal de-rotation 
was then suggested as the ligament of Treitz had been seve-
red during the first procedure. Intraoperatively, the ligament 
was found adhered to its original place, suggesting post-ope-
rative adhesion formation. The patient reported that all of the 
pre-operative symptoms were almost completely alleviated.
One female patient who was involved in our study developed 
SMAS after her deterioration of health following a partial hys-
terectomy with the da Vinci robot in February 2013. This ad-
vanced technique was believed to cause damage and severe 
organ prolapse which led to traction of SMA with the resultant 
duodenal compression. However, more evidence is needed to 
support this hypothesis.
Another factor that can be considered is the rapid growth in 
height without the appropriate and corresponding weight gain 
in children, which in turn narrows the aortomesenteric angle 
and causes SMAS.1,18 In addition, postoperative weight loss, 
prolonged bed rest as a result of chronic illness or severe trau-
ma, asthenic habitus, sagittal kyphosis and scoliosis surgery 
had also been reported by some authors as contributing fac-
tors.1,4,17,19
Some important and typical complaints from patients are chro-
nic post-prandial abdominal pain with intermittent exacerba-
tion that are relieved by the knee-to-chest position, nausea, 
and progressive vomiting that increased in intensity and fre-
quency.1,4,7,14-16,20,26 Vomitus usually consisted of undigested 
food.7 This constellation of symptoms is concurrent with the 
majority of our cases.
Only five cases (14.3%) were diagnosed as early as three mon-
ths after the onset of symptoms. Most patients were diagnosed 
within 1–5 years of suffering, suggesting the lack of awareness 
among physicians regarding this rare disorder. Interestingly, it 
took almost 10 years or more for five (14.3%) of our cases to 
be diagnosed. Delay in diagnosis and proper management will 
leads to the development of co-morbidities such as malnu-
trition, dehydration, electrolytes imbalance and even death.14
UGI series is usually sufficient for diagnosis in most cases. The 
appearance of dilated proximal duodenum with an abrupt dis-
continuation of the barium flow in the third part might also be 
seen in cases of megaduodenum.9,15 UGI series does not seem 
to be sensitive enough due to the intermittent course of SMAS 
symptoms, hence it is generally suitable during an active at-
tack.8 Therefore, diagnosis of most of our patients (82.9%) were 
established by contrast-enhanced abdominal CT scan, which 
could show the compression and reduced angle both in symp-
tomatic and asymptomatic patients. Other signs of obstruction 
can also be seen such as a distended stomach and a dilated 
proximal duodenum.6,8,16
With regard to treatment, conservative measures should be at-
tempted prior to surgery.10,11,24 The goal for this approach is to 
encourage restoration of retroperitoneal fat, with subsequent 
increase of the aortomesenteric angle and reduction in duode-
nal compression.1,8,14 Acute cases with a short history, moderate 
symptoms and incomplete duodenal obstruction may benefit 
from this regimen.11 In our review, the success rate of medical 
therapy is as low as 11.1, similar to that reported in the study 
by Ha et al. (14%).13 Burrington (1976)9 reported that 70% of 
patients required surgical intervention in spite of the benefit 
in advances of both enteral and parenteral nutrition made in 
the last 30 years. Children and adults with a short history may 
benefit from this approach. However, most of these patients 
are critically ill, requiring prolonged hospital stay with a low 
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An overall review on the prognosis proved that majority of 
the patients are still in need of supervision regardless of their 
method of treatment. About 87% of our cases that had recei-
ved treatment are still struggling with the ongoing symptoms 
that either persisted or re-appeared. Five patients (14.3%) were 
diagnosed with SMAS and had yet to receive any interventions.
Some limitations of our study were clearly recognized. In an 
online survey, participation is usually unpredictable. Only a 
small number of cases enrolled in our study and majority of 
them were living in the same continent, rendering a difficult 
evaluation on the worldwide management trend. In addition, 
some patients might have provided inaccurate or inadequa-
te information regarding their condition due to recall bias. An 
extensive future study with a large number of cases using a 
proper study design is advocated.
As a conclusion, diagnosis of SMAS is established after a tho-
rough assessment of the clinical presentations and confirma-
tion with suitable imaging modalities. The similarity of clinical 
presentations in SMAS and other gastrointestinal issues might 
complicate the diagnosis; however, they can be distinguished 
easily by certain imaging techniques which can identify the 
decrease in the aortomesenteric angle and distance. The choice 
of treatment should be dependent on the causes and severity, 
as different patients respond differently to various therapies. 
Recurrence of obstruction or development of complication is 
possible and thus a long-term follow up plan is required in all 
patients.
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